Streetbeat News

Stock Prices

BE

Bloom Energy (NYSE:BE) has received three somewhat bullish ratings and one indifferent rating from analysts in the last quarter. The average price target is $25.25, representing an upside from the current price of $15.385. This average is a 5.32% decrease from the previous average price target of $26.67.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

DNLI

Analysts have provided bullish and somewhat bullish ratings for Denali Therapeutics (NASDAQ:DNLI) in the last quarter. The average price target for the stock is $81.12, a significant increase from the previous average of $53.50. The current price of Denali Therapeutics is $23.1.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

CTLT

In the last quarter, 15 analysts have given ratings for Catalent (NYSE:CTLT) with 2 being bullish, 7 somewhat bullish, and 6 indifferent. The company has an average 12-month price target of $49.27, which has increased by 8.84% over the past month.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

OSK

Over the past 3 months, 11 analysts have published their opinion on Oshkosh (NYSE:OSK) stock. The average price target for Oshkosh is $112.0, with a high of $137.00 and a low of $95.00. This average price target has increased by 16.4% over the past month.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

APO

Apollo Global Management (NYSE:APO) has outperformed the market over the past 10 years, producing an average annual return of 12.46%. If an investor had bought $100 of APO stock 10 years ago, it would be worth $333.11 today.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

AYX

In the last quarter, Alteryx (NYSE:AYX) received 4 bullish, 2 somewhat bullish, and 4 indifferent analyst ratings. The average 12-month price target for Alteryx, according to 10 analysts, is $48.2, a decrease of 28.8% from the previous average of $67.70.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

MU

Micron Technology (NASDAQ:MU) has outperformed the market over the past 10 years by 6.28% on an annualized basis, producing an average annual return of 16.83%. If an investor had bought $1000 of MU stock 10 years ago, it would be worth $4,990.72 today.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

ANET

Arista Networks (NYSE:ANET) has received 18 analyst ratings in the last quarter, with 6 being bullish, 9 somewhat bullish, and 3 indifferent. The average 12-month price target for the company is $198.61, which has increased by 10.67% over the past month.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 2:00 pm

ACER

Shares of Acer Therapeutics have resumed trading.

Portfolio Pulse from Happy Mohamed

August 31, 2023 | 1:58 pm

ALLR

Allarity Therapeutics Inc's shares are trading higher after the company published clinical data validating a novel drug-specific DRP-companion diagnostic (CDx) for dovitinib in PLOS ONE. The data showed a subgroup of advanced renal cell carcinoma (RCC) patients that have improved clinical benefit from treatment with dovitinib. The DRP-Dovitinib CDx is a complex transcriptomic signature comprising 58 mRNA biomarkers that can predict tumor response to the drug.

Portfolio Pulse from Adam Eckert

August 31, 2023 | 1:57 pm